A more detailed analysis comparing the therapeutic effectiveness of agents used to treat PHN may be found in multiple recently published reviews (Young 2006; Saarto and Wiffen 2007; Schmader 2007a).
Multiple recently published research studies and protocols propose a common intervention for different types of cancer, personalized to patient needs, which undoubtedly makes these interventions more cost-effective than those focused specifically on single types of cancer [ 22, 25, 28].
A pragmatic decision was made to rely on the APACHE II (rather than more recent versions of APACHE) in view of its practicality, the fact that it is the only available non-proprietary version in widespread clinical use [1, 2, 4] and the comparator of choice in multiple other recently published studies [53, 54].
We assemble a list of DM2-associated genes from multiple sources, a recently published article [24] and three public databases.
In a recently published multiple-treatment meta-analysis by Cipriani and collegues (Lancet, 2009) the authors finally concluded to favour sertralin over escitalopram due to lower costs.
Smith, a believer in developing the Vice brand over multiple media platforms, pointed to recently published figures that appear to show that the BBC has lost young viewers since closing the channel.
In situations where multiple matches were found, the most recently published SR of RCTs was chosen.
Securin is a recently published oncogene with multiple functions in tumourigenesis and progression, invasion, and metastasis of malignant disease, and, therefore, further investigations are needed to evaluate the possible prognostic and therapeutic applications of securin in treatment decisions of individual breast cancer patients.
The data from HORIZON II, comparing the VEGF signalling inhibitor cediranib with placebo on the background of chemotherapy, although concurrent with the recently published evaluation of multiple studies by Hegde et al (2013), are not consistent with data from the AVADO study (Miles et al, 2010).
For example, a recent study reports that the false positive and negative rates of yeast two-hybrid protein protein interaction data could be as high as 25 45% and 75 90%, respectively (Huang et al., 2007), and a recently published dataset combining multiple large-scale yeast two-hybrid screens is estimated to cover only 20% of the yeast binary interactome (Yu et al., 2008).
The recently published phase 2 multiple-ascending-dose trial in mild to moderate AD tested the safety and efficacy of bapineuzumab [ 8].
